Status:
COMPLETED
A Study of Xenical (Orlistat) in Overweight and Obese Adolescents
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Obesity
Eligibility:
All Genders
12-14 years
Phase:
PHASE3
Brief Summary
This 2 arm study will assess the effect of Xenical on body mass index (BMI)in obese or overweight adolescents. Patients will be randomised into one of 2 groups; both groups will undergo a regimen of m...
Eligibility Criteria
Inclusion
- adolescent patients, 12-14 years of age
- overweight or obese
Exclusion
- age \<12 or \>14 years
- BMI in normal range
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00940628
Start Date
April 1 2008
End Date
September 1 2010
Last Update
April 5 2016
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Kazan', Russia, 420073
2
Khabarovsk, Russia, 680063
3
Krasnodar, Russia, 350013
4
Krasnoyarsk, Russia, 660074